While the innovation sphere constantly focuses on artificial intelligence these days, the top players in the field have gotten a lot of attention – maybe too much attention. Recently, we've seen the mighty Nvidia (NASDAQ: NVDA ) lose a step from its previously mercurial ways.

Tue, Jun. 25, 2024

After two decades of successfully scaling multiple healthcare companies, Steven Nelson joins DarioHealth as Chief Commercial Officer to accelerate revenue growth across the health plans, employers and pharma channels NEW YORK , June 5, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario", "DarioHealth" or the "Company"), a leader in the global digital health market, announced today a strategic reorganization designed to streamline leadership and focus the organization on accelerating its commercialization efforts. This move reflects the Company's commitment to bringing its innovative solutions to the market faster, maximizing customer impact, and driving the organization to profitability.

Wed, Jun. 05, 2024

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to earnings of $0.45 per share a year ago.

Wed, May. 15, 2024

First quarter revenue of $ 5.8 million reflects an increase of 59% over fourth quarter of 2023 primarily resulting from an increase in B2B2C revenues and reflects a decrease of 18.5% compared to the first quarter of 2023 due to milestone driven revenues. Core revenue channel B2B2C, employers and health plans recurring revenues in the first quarter totaled $3.47 million, an increase of  176% year over year and 210% sequentially from $1.12 million in the fourth quarter 2023 as the core business continues to gain traction, as well as the addition of Twill Inc. revenues post February 15 th closing Launched the Aetna platform generating revenue in Q1 2024 as Aetna continues to add employers to the platform Accelerated path to profitability through growing revenues in the B2B2C channel which represents proforma of $22M in annual recurring revenue ("ARR") Executing on Dario-Twill synergies that we expect to reduce operating expenses by 30% by the fourth quarter of 2024 Company anticipates reaching a breakeven run rate in the second half of 2025 Ended Q1 2024 with cash equivalents of $34.7 million Company to host investor conference call and webcast at 8:30 a.m.

Wed, May. 15, 2024

Company to host conference call and webcast at 8:30am ET NEW YORK , May 7, 2024 /PRNewswire/ --  DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 1st quarter ended March 31st, 2024, on Wednesday, May 15th, 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time. Erez Raphael, Chief Executive Officer and Rick Anderson, President, will host the call.

Tue, May. 07, 2024